Go to deals
Healthcare

Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank

Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.

Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).

Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.

Talk to the deal team

Giuseppe Maria Bernardo Puccio

Principal
Milan, Italy
Oaklins Italy

Related deals

Foreman Capital has raised financing for the acquisition of Rijcken Groep
Private Equity | Food & Beverage

Foreman Capital has raised financing for the acquisition of Rijcken Groep

Foreman Capital, a Netherlands-based private equity firm, has secured debt financing for the acquisition of international food wholesaler Rijcken Groep. The financing package, provided through a club deal by Rabobank and ING, is designed to support Rijcken Groep’s organic growth as well as its planned buy-and-build strategy.

Learn more
Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more